263 related articles for article (PubMed ID: 25222909)
21. Can complementary 68Ga-DOTATATE and 18F-FDG PET/CT establish the missing link between histopathology and therapeutic approach in gastroenteropancreatic neuroendocrine tumors?
Has Simsek D; Kuyumcu S; Turkmen C; Sanlı Y; Aykan F; Unal S; Adalet I
J Nucl Med; 2014 Nov; 55(11):1811-7. PubMed ID: 25315243
[TBL] [Abstract][Full Text] [Related]
22. High folate receptor expression in gliomas can be detected
Miner MWG; Liljenbäck H; Virta J; Kärnä S; Viitanen R; Elo P; Gardberg M; Teuho J; Saipa P; Rajander J; Mansour HMA; Cleveland NA; Low PS; Li XG; Roivainen A
Front Immunol; 2023; 14():1145473. PubMed ID: 37275898
[TBL] [Abstract][Full Text] [Related]
23. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG.
Chen W; Cloughesy T; Kamdar N; Satyamurthy N; Bergsneider M; Liau L; Mischel P; Czernin J; Phelps ME; Silverman DH
J Nucl Med; 2005 Jun; 46(6):945-52. PubMed ID: 15937304
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
[TBL] [Abstract][Full Text] [Related]
25. Predictive Value of [
Gu B; Liu S; Sun Y; Zhang J; Zhang Y; Xu X; Yuan H; Wang M; Zhang Y; Yang Z
Mol Imaging Biol; 2019 Jun; 21(3):538-548. PubMed ID: 30218389
[TBL] [Abstract][Full Text] [Related]
26. FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values.
Nguyen XC; Lee WW; Chung JH; Park SY; Sung SW; Kim YK; So Y; Lee DS; Chung JK; Lee MC; Kim SE
Eur J Radiol; 2007 May; 62(2):214-9. PubMed ID: 17239556
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of diethylnitrosamine- or hepatitis B virus X gene-induced hepatocellular carcinoma with 18F-FDG PET/CT: a preclinical study.
Park JH; Kang JH; Lee YJ; Kim KI; Lee TS; Kim KM; Park JA; Ko YO; Yu DY; Nahm SS; Jeon TJ; Park YS; Lim SM
Oncol Rep; 2015 Jan; 33(1):347-53. PubMed ID: 25371060
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET/CT features of pulmonary sclerosing hemangioma.
Lee E; Park CM; Kang KW; Goo JM; Kim MA; Paeng JC; Lee HJ; Park HS; Chung DH
Acta Radiol; 2013 Feb; 54(1):24-9. PubMed ID: 22291338
[TBL] [Abstract][Full Text] [Related]
29. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
[TBL] [Abstract][Full Text] [Related]
30. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S
Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
[TBL] [Abstract][Full Text] [Related]
31. [18F]FLT and [18F]FDG PET for non-invasive treatment monitoring of the nicotinamide phosphoribosyltransferase inhibitor APO866 in human xenografts.
Jensen MM; Erichsen KD; Johnbeck CB; Björkling F; Madsen J; Bzorek M; Jensen PB; Højgaard L; Sehested M; Kjær A
PLoS One; 2013; 8(1):e53410. PubMed ID: 23308217
[TBL] [Abstract][Full Text] [Related]
32. Biological characteristics of intratumoral [F-18]‑fluoromisonidazole distribution in a rodent model of glioma.
Hatano T; Zhao S; Zhao Y; Nishijima K; Kuno N; Hanzawa H; Sakamoto T; Tamaki N; Kuge Y
Int J Oncol; 2013 Mar; 42(3):823-30. PubMed ID: 23338175
[TBL] [Abstract][Full Text] [Related]
33. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
36. 18F-FDG uptake in primary gastric malignant lymphoma correlates with glucose transporter 1 expression and histologic malignant potential.
Watanabe Y; Suefuji H; Hirose Y; Kaida H; Suzuki G; Uozumi J; Ogo E; Miura M; Takasu K; Miyazaki K; Nakahara K; Ishibashi M; Okamura T; Ohshima K; Hayabuchi N
Int J Hematol; 2013 Jan; 97(1):43-9. PubMed ID: 23212465
[TBL] [Abstract][Full Text] [Related]
37. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
[TBL] [Abstract][Full Text] [Related]
38. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
Kim Y; Lee HY; Yoon HJ; Kim BS
J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
40. No relationship between 18F-fluorodeoxyglucose positron emission tomography and expression of Glut-1 and -3 and hexokinase I and II in high-grade glioma.
Charnley N; Airley R; Du Plessis D; West C; Brock C; Barnett C; Matthews J; Symonds K; Bottomly M; Swindell R; Price P
Oncol Rep; 2008 Sep; 20(3):537-42. PubMed ID: 18695903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
